MOQ | 20 pcs |
Port | Incheon Port |
Packaging | Original |
Lead Time | 7 days |
Quality | Premium | Lead | 6 to 10 days |
Packaging | boxes | MOQ | 30 pcs |
Description: StarFill Lidocaine presents a
dermal filler based on cross-linked hyaluronic acid (HA).
Starfill fillers are obtained using the “Zero Endotoxin and BDDE
Entire Process” (ZEEP) technology, which guarantees minimized
endotoxin and residual BDDE levels. The product has high HA
cross-linking degree, outstanding viscoelasticity and
cohesiveness parameter values. Low toxin and cross-linking agent
levels ensure high safety of the product while minimizing the
risk of post-injection edema, allergic reactions, and other side
effects. Uniform gel particle size contributes to even
distribution of the filler during injection and better aesthetic
effect. The presence of lidocaine in the composition makes the
procedure painless.
Strengths of StarFill:
l the series contains products varying in the gel particle size and HA cross-linking rate depending on the scope of use
l endotoxin level is below 0.1 EU/ml
l no residual BDDE
l even distribution of the gel during injection due to uniform particle size
l high viscoelasticity and cohesiveness result in longer aesthetic effect duration
l proven effectiveness as demonstrated by the Wrinkle Severity Rating Scale (WSRS) results of the assessment of wrinkle improvement on week 8, 16, and 24 after the injection procedure
l have CE certificate
l The aesthetic effect lasts from 9 to 15 months.
Product composition: Cross-linked sodium hyaluronate 24 mg/ml, Lidocaine hydrochloride 3 mg/ml, PBS
1 syringe × 1.1 ml, 2 needles per pack
Manufacturer: JETEMA Co., Ltd., South Korea